Oncocyte Corp Stock Price History
| OCX Stock | USD 3.62 0.08 2.16% |
Below is the normalized historical share price chart for OncoCyte Corp extending back to December 30, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of OncoCyte Corp stands at 3.62, as last reported on the 19th of March, with the highest price reaching 3.73 and the lowest price hitting 3.56 during the day.
If you're considering investing in OncoCyte Stock, it is important to understand the factors that can impact its price. OncoCyte Corp appears to be very risky, given 3 months investment horizon. OncoCyte Corp maintains Sharpe Ratio (i.e., Efficiency) of 0.19, which implies the firm had a 0.19 % return per unit of risk over the last 3 months. By analyzing OncoCyte Corp's technical indicators, you can evaluate if the expected return of 0.96% is justified by implied risk. Please evaluate OncoCyte Corp's Risk Adjusted Performance of 0.1394, coefficient of variation of 668.97, and Semi Deviation of 2.81 to confirm if our risk estimates are consistent with your expectations.
At this time, OncoCyte Corp's Common Stock Total Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 9.2 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 22 M in 2025. . Price Earnings To Growth Ratio is likely to rise to 0.01 in 2025, whereas Price To Sales Ratio is likely to drop 13.90 in 2025. OncoCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of January 2016 | 200 Day MA 2.8102 | 50 Day MA 2.5865 | Beta 0.794 |
OncoCyte |
Sharpe Ratio = 0.1889
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OCX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.09 actual daily | 45 55% of assets are more volatile |
Expected Return
| 0.96 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average OncoCyte Corp is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OncoCyte Corp by adding it to a well-diversified portfolio.
Price Book 10.985 | Enterprise Value Ebitda (1.25) | Price Sales 149.2488 | Shares Float 6.4 M | Wall Street Target Price 4.125 |
OncoCyte Corp Stock Price History Chart
There are several ways to analyze OncoCyte Stock price data. The simplest method is using a basic OncoCyte candlestick price chart, which shows OncoCyte Corp price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 10, 2025 | 4.17 |
| Lowest Price | January 22, 2025 | 1.96 |
OncoCyte Corp March 19, 2025 Stock Price Synopsis
Various analyses of OncoCyte Corp's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell OncoCyte Stock. It can be used to describe the percentage change in the price of OncoCyte Corp from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of OncoCyte Stock.| OncoCyte Corp Accumulation Distribution | 924.84 | |
| OncoCyte Corp Price Daily Balance Of Power | (0.47) | |
| OncoCyte Corp Price Rate Of Daily Change | 0.98 | |
| OncoCyte Corp Price Action Indicator | (0.06) |
OncoCyte Corp March 19, 2025 Stock Price Analysis
OncoCyte Stock Price History Data
The price series of OncoCyte Corp for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 2.21 with a coefficient of variation of 23.31. The daily prices for the period are spread out with arithmetic mean of 2.51. The median price for the last 90 days is 2.32. The company underwent 1:20 stock split on 25th of July 2023.| Open | High | Low | Close | Volume | ||
| 03/18/2025 | 3.65 | 3.73 | 3.56 | 3.62 | 20,292 | |
| 03/17/2025 | 3.75 | 3.77 | 3.16 | 3.70 | 119,362 | |
| 03/14/2025 | 3.92 | 3.93 | 3.50 | 3.74 | 62,984 | |
| 03/13/2025 | 3.68 | 3.90 | 3.25 | 3.87 | 128,321 | |
| 03/12/2025 | 4.08 | 4.08 | 3.44 | 3.79 | 166,421 | |
| 03/11/2025 | 4.16 | 4.75 | 3.70 | 4.09 | 412,966 | |
| 03/10/2025 | 3.88 | 4.18 | 3.60 | 4.17 | 216,977 | |
| 03/07/2025 | 3.69 | 4.17 | 3.65 | 3.90 | 83,083 | |
| 03/06/2025 | 3.74 | 3.79 | 3.40 | 3.64 | 130,361 | |
| 03/05/2025 | 3.17 | 3.95 | 2.97 | 3.62 | 224,229 | |
| 03/04/2025 | 2.70 | 3.19 | 2.63 | 3.19 | 105,519 | |
| 03/03/2025 | 2.80 | 2.85 | 2.60 | 2.78 | 175,481 | |
| 02/28/2025 | 2.76 | 2.80 | 2.52 | 2.80 | 179,389 | |
| 02/27/2025 | 2.60 | 2.60 | 2.51 | 2.57 | 45,334 | |
| 02/26/2025 | 2.51 | 2.70 | 2.51 | 2.58 | 22,624 | |
| 02/25/2025 | 2.57 | 2.60 | 2.32 | 2.52 | 47,941 | |
| 02/24/2025 | 2.65 | 2.68 | 2.57 | 2.63 | 22,329 | |
| 02/21/2025 | 2.78 | 2.79 | 2.57 | 2.65 | 51,737 | |
| 02/20/2025 | 2.80 | 2.85 | 2.61 | 2.72 | 48,208 | |
| 02/19/2025 | 2.74 | 2.84 | 2.71 | 2.76 | 97,046 | |
| 02/18/2025 | 2.55 | 2.80 | 2.51 | 2.70 | 107,528 | |
| 02/14/2025 | 2.35 | 2.57 | 2.35 | 2.56 | 73,907 | |
| 02/13/2025 | 2.49 | 2.49 | 2.21 | 2.38 | 120,921 | |
| 02/12/2025 | 2.48 | 2.60 | 2.30 | 2.51 | 226,924 | |
| 02/11/2025 | 2.18 | 2.58 | 2.07 | 2.37 | 362,479 | |
| 02/10/2025 | 2.03 | 2.12 | 1.97 | 2.07 | 41,877 | |
| 02/07/2025 | 2.08 | 2.17 | 1.95 | 2.01 | 35,367 | |
| 02/06/2025 | 2.07 | 2.13 | 2.05 | 2.05 | 16,472 | |
| 02/05/2025 | 2.15 | 2.18 | 2.07 | 2.16 | 21,078 | |
| 02/04/2025 | 2.10 | 2.29 | 2.06 | 2.13 | 39,975 | |
| 02/03/2025 | 2.09 | 2.14 | 1.99 | 2.13 | 52,517 | |
| 01/31/2025 | 2.09 | 2.42 | 2.01 | 2.07 | 367,380 | |
| 01/30/2025 | 2.01 | 2.06 | 2.01 | 2.01 | 6,162 | |
| 01/29/2025 | 2.01 | 2.06 | 2.01 | 2.02 | 15,642 | |
| 01/28/2025 | 2.09 | 2.09 | 2.02 | 2.03 | 23,602 | |
| 01/27/2025 | 2.05 | 2.07 | 2.02 | 2.03 | 20,286 | |
| 01/24/2025 | 2.04 | 2.08 | 2.01 | 2.03 | 12,344 | |
| 01/23/2025 | 1.96 | 2.06 | 1.96 | 2.01 | 16,463 | |
| 01/22/2025 | 2.07 | 2.09 | 1.92 | 1.96 | 119,061 | |
| 01/21/2025 | 2.08 | 2.18 | 2.07 | 2.12 | 98,982 | |
| 01/17/2025 | 2.15 | 2.15 | 2.08 | 2.08 | 28,120 | |
| 01/16/2025 | 2.24 | 2.24 | 2.08 | 2.10 | 27,314 | |
| 01/15/2025 | 2.18 | 2.20 | 2.08 | 2.20 | 34,695 | |
| 01/14/2025 | 2.10 | 2.28 | 2.05 | 2.15 | 79,662 | |
| 01/13/2025 | 2.20 | 2.31 | 2.06 | 2.08 | 37,380 | |
| 01/10/2025 | 2.26 | 2.32 | 2.13 | 2.21 | 8,211 | |
| 01/08/2025 | 2.30 | 2.33 | 2.18 | 2.23 | 16,439 | |
| 01/07/2025 | 2.32 | 2.43 | 2.18 | 2.22 | 11,865 | |
| 01/06/2025 | 2.39 | 2.45 | 2.23 | 2.29 | 48,294 | |
| 01/03/2025 | 2.37 | 2.38 | 2.31 | 2.37 | 16,082 | |
| 01/02/2025 | 2.31 | 2.38 | 2.23 | 2.33 | 23,400 | |
| 12/31/2024 | 2.52 | 2.60 | 2.33 | 2.38 | 47,442 | |
| 12/30/2024 | 2.25 | 2.69 | 2.16 | 2.45 | 347,765 | |
| 12/27/2024 | 1.97 | 2.20 | 1.97 | 2.11 | 81,841 | |
| 12/26/2024 | 2.15 | 2.23 | 2.04 | 2.13 | 273,969 | |
| 12/24/2024 | 2.16 | 2.21 | 2.15 | 2.16 | 21,123 | |
| 12/23/2024 | 2.21 | 2.25 | 2.19 | 2.19 | 9,992 | |
| 12/20/2024 | 2.15 | 2.27 | 2.15 | 2.19 | 78,197 | |
| 12/19/2024 | 2.28 | 2.28 | 2.18 | 2.21 | 138,346 | |
| 12/18/2024 | 2.22 | 2.36 | 2.18 | 2.20 | 51,097 | |
| 12/17/2024 | 2.22 | 2.31 | 2.19 | 2.21 | 16,736 |
About OncoCyte Corp Stock history
OncoCyte Corp investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for OncoCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in OncoCyte Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing OncoCyte Corp stock prices may prove useful in developing a viable investing in OncoCyte Corp
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 8.8 M | 9.2 M | |
| Net Loss | -66.1 M | -62.8 M |
OncoCyte Corp Stock Technical Analysis
OncoCyte Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
OncoCyte Corp Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for OncoCyte Corp's price direction in advance. Along with the technical and fundamental analysis of OncoCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of OncoCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1394 | |||
| Jensen Alpha | 0.7121 | |||
| Total Risk Alpha | 1.23 | |||
| Sortino Ratio | 0.2449 | |||
| Treynor Ratio | (5.68) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for OncoCyte Stock Analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.